can semaglutide cause high blood sugar GLP-1 Side Effects and Semaglutide:

(2020) Full-length human GLP-1 receptor structure without orthosteric ligands

Similar patterns appeared in other obesity-related cancers: Non-small cell lung cancer: progression to Stage IV roughly 10% versus 22% Colorectal cancer: statistically significant reduction in progression Hepatocellular (liver) cancer: signal in the same direction A separate JAMA Oncology study by Dai and colleagues (2025), distinct from the Cleveland Clinic ASCO analysis, found about a 17% lower overall cancer incidence (hazard ratio approximately 0.83) in adults with obesity who used GLP-1 receptor agonists, with most of the signal coming from skin cancers and obesity-related solid tumors

Patients often recover faster than they thought possible

Ivania Rizo, Director of Obesity Medicine at Boston Medical Center told Spotlight on America